June 15-19 • OM1 Booth #2006
Walter E. Washington Convention Center 801 Allen Y. Lew Place NW, Washington, DC 20001
Join OM1 at DIA 2025
Title: | Real-World Evidence Generation in a Demanding Era | |
Date: | Monday, June 16 – Day 1 | |
Location: | Innovation Theatre #2 | |
Presenter: | Eric Schrock, CTO and Head of Evidence Generation Solutions | |
Overview: | As the demand for faster, more agile, and cost-effective evidence generation grows, traditional observational studies are showing their limitations-slow site activation, burdensome operations, and limited scalability. This session explores how automation and AI are modernizing approaches to real-world observational programs. Join us to discover how leading life sciences are using AI-powered real-world data solutions to streamline prospective studies, post-marketing commitments, and regulatory-required evidence generation. Learn how these technologies enable long-term, scalable, and diverse patient engagement while meeting the rigorous demands of regulatory authorities and supporting product differentiation in real-world settings. |
Title: | Real-World Evidence: First Choice or Last Resort? | |
Date: | Monday, June 16 – Day 1 | 11:00AM | |
Location: | 207B | |
Chair: | Nancy Dreyer, PhD, MPH, FISPE | |
Speaker: | Richard Gliklich, MD (RWE for Clinical Decision Support) |
|
Speaker: | Brian Bradbury, DrSc, MA (Opportunities and Challenges in Using RWE from the Perspective of Drug Development) |
|
Speaker: | Patrice Verpillat, DrMed, MD, PhD, MPH (How Regulators are Collaborating with Payers: Update on EMA-HTA Pilot Work) |
|
Overview: |
|
Meet the team
![]() Richard Gliklich, Founder, OM1 |
![]() Eric Schrock, CTO and Head of Evidence Generation Solutions |
![]() Mark Hogendobler, Senior Director, RWE and AI Solutions Architect |
![]() Todd Price, Senior Director, Business Development |
![]() Jodi Silva, Marketing Manager |
![]() Nancy Dreyer, PhD, MPH, FISPE, Chief Scientific Advisor and Chief, Scientific Advisory Board |